title: Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.
abstract: The aim of this study was to ascertain whether assessing the growth fraction of cervical carcinoma of 28 patients, using antibody Ki-67, would be of value in clinical practice. The results showed no relationship between growth fraction and age, clinical stage, lymph node involvement or short term (3-5 years) survival.
authors.affiliation: Department of Radiotherapy and Oncology, Churchill Hospital, Oxford, UK.
authors.forename: D J
authors.initials: DJ
authors.lastname: Cole
authors.forename: D C
authors.initials: DC
authors.lastname: Brown
authors.forename: E
authors.initials: E
authors.lastname: Crossley
authors.forename: C J
authors.initials: CJ
authors.lastname: Alcock
authors.forename: K C
authors.initials: KC
authors.lastname: Gatter
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D002455:Cell Division / Q000502:physiology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen; D008875:Middle Aged; D009687:Nuclear Proteins / Q000032:analysis; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D019394:Ki-67 Antigen; D009687:Nuclear Proteins